Friday, October 27, 2017

Endo moves to protect Vasostrict franchise with FDA lawsuit; shares ...

Seeking Alpha-10 hours ago
Category 1-listed products can be freely compounded because they do not present a significant safety risk in compounding. Endo Chief Legal Officer Matthew .

No comments: